NCT00168298 - A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion | Biotech Hunter

Enrollment

668

Participants

Timeline

Start Date

November 1, 2004

Primary Completion Date

March 1, 2008

Study Completion Date

September 5, 2008

Conditions

Macular EdemaRetinal Vein Occlusion

Interventions

DRUG

700 µg Dexamethasone

700 µg dexamethasone intravitreal implant administered on Day 0 and/or Day 180.

DRUG

350 µg Dexamethasone

350 µg Dexamethasone intravitreal implant administered on Day 0.

OTHER

Sham Injection

Sham injection on Day 0.

Trial Locations (13)

Houston

São Paulo

Mississauga

Bogotá

Kowloon

Tamil Nadu

Udine

Auckland

Poznan

Singapore

Seoul

Alicante

London